{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:27:25Z","timestamp":1790011645836,"version":"4.0.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,14]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Glioblastoma (GBM) is the most common primary malignant intracranial tumor in adults. GBMs with primitive neuronal components (GBM-PNC) represent a rare subtype of GBM, accounting for 0.5% of cases, often characterized by cerebrospinal fluid (CSF) dissemination and extracranial metastasis (ECM). Among the primitive neuronal components (PNC), MYC gene amplification is found in 43% of cases. Once diagnosed, treatment becomes extremely challenging; therefore, early identification and timely intervention are crucial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 60-year-old male presented with a 5-day history of headache and limb weakness. He had no prior neurological disorders and no family history of brain tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Magnetic resonance imaging of the head revealed a heterogeneously enhancing mass adjacent to the right lateral ventricle. Although postoperative immunohistochemistry, MYC gene amplification on molecular testing, and disease progression were consistent with the characteristics of GBM-PNC, the absence of corresponding morphological evidence led to a diagnosis of GBM NOS, World Health Organization grade IV. Postoperative examination demonstrated tumor metastases in the head, thoracic, and lumbosacral regions, suggesting ECM spread via CSF dissemination. In combination with the pathological findings, the case was ultimately considered a transitional or atypical GBM-PNC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>After evaluating the patient\u2019s condition, the tumor was completely resected surgically. Postoperatively, the patient underwent radiotherapy, chemotherapy, and regular follow-up. Two months later, tumor metastases were detected. In addition to the original treatment regimen, intrathecal methotrexate injections were administered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Two months after surgery, tumor metastasis was detected. Treatment with radiotherapy, chemotherapy, and intrathecal drug injections effectively controlled disease progression. However, the patient\u2019s condition deteriorated 10 months postoperatively, and he ultimately passed away 14 months after the initial surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>Based on this case and a review of relevant literature, it can be inferred that MYC amplification may serve as an early predictive biomarker for ECM via CSF dissemination in GBM. Furthermore, MYC gene overexpression may promote the transformation of primitive cells, and this case may represent a transitional or atypical GBM-PNC. This case suggests that clinicians should remain vigilant for the potential of CSF dissemination and ECM in GBM patients, particularly when MYC amplification is present, which could serve as an early warning of distant metastasis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000044072","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T21:01:19Z","timestamp":1763154079000},"page":"e44072","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Glioblastoma with cerebrospinal fluid dissemination and MYC gene amplification: A transitional or atypical glioblastoma with primitive neuronal components"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0760-1728","authenticated-orcid":false,"given":"Wenhui","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, The Second Hospital of Tianjin Medical University, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihao","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxue","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8989-0710","authenticated-orcid":false,"given":"Yi","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20251121","doi-asserted-by":"crossref","first-page":"104647","DOI":"10.1016\/j.critrevonc.2025.104647","article-title":"Signaling pathways in glioblastoma.","volume":"209","author":"Gomes","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"R2-20251121","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary.","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"R3-20251121","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1200\/JCO.2006.08.1497","article-title":"Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas.","volume":"24","author":"Miller","year":"2006","journal-title":"J Clin Oncol"},{"key":"R4-20251121","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1750-3639.2008.00167.x","article-title":"Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases.","volume":"19","author":"Perry","year":"2009","journal-title":"Brain Pathol"},{"key":"R5-20251121","doi-asserted-by":"crossref","first-page":"E264","DOI":"10.1097\/BRS.0b013e3181c11748","article-title":"Spinal metastasis of glioblastoma multiforme: an uncommon suspect?","volume":"35","author":"Birbilis","year":"2010","journal-title":"Spine (Phila Pa 1976)"},{"key":"R6-20251121","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jocn.2004.11.004","article-title":"Spinal and extracranial metastatic dissemination of malignant glioma.","volume":"12","author":"Ng","year":"2005","journal-title":"J Clin Neurosci"},{"key":"R7-20251121","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00006123-199608000-00001","article-title":"Glioma invasion in the central nervous system.","volume":"39","author":"Giese","year":"1996","journal-title":"Neurosurgery"},{"key":"R8-20251121","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00401-008-0368-0","article-title":"c-MYC amplification and expression in astrocytic tumors.","volume":"116","author":"Faria","year":"2008","journal-title":"Acta Neuropathol"},{"key":"R9-20251121","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/bjc.1992.225","article-title":"Overexpression of multiple oncogenes related to histological grade of astrocytic glioma.","volume":"66","author":"Orian","year":"1992","journal-title":"Br J Cancer"},{"key":"R10-20251121","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/ng.3457","article-title":"Integrated genomic characterization of IDH1-mutant glioma malignant progression.","volume":"48","author":"Bai","year":"2016","journal-title":"Nat Genet"},{"key":"R11-20251121","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/labinvest.3780280","article-title":"Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization.","volume":"81","author":"Hui","year":"2001","journal-title":"Lab Invest"},{"key":"R12-20251121","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00401-019-02056-2","article-title":"MYCN amplification drives an aggressive form of spinal ependymoma.","volume":"138","author":"Ghasemi","year":"2019","journal-title":"Acta Neuropathol"},{"key":"R13-20251121","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/neuonc\/noae178","article-title":"Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: a multicenter cohort study.","volume":"27","author":"Schwalbe","year":"2025","journal-title":"Neuro Oncol"},{"key":"R14-20251121","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00401-011-0923-y","article-title":"MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma.","volume":"123","author":"Ryan","year":"2012","journal-title":"Acta Neuropathol"},{"key":"R15-20251121","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000533270","article-title":"MYC promotes aggressive growth and metastasis of a WNT-medulloblastoma mouse model.","volume":"46","author":"Hartley","year":"2024","journal-title":"Dev Neurosci"},{"key":"R16-20251121","doi-asserted-by":"crossref","first-page":"148033","DOI":"10.1016\/j.gene.2023.148033","article-title":"LINC02561 promotes metastasis in HCC via HIF1-\u03b1\/NDRG1\/UPF1 axis.","volume":"896","author":"Li","year":"2023","journal-title":"Gene"},{"key":"R17-20251121","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1038\/s41388-023-02861-w","article-title":"MYC in liver cancer: mechanisms and targeted therapy opportunities.","volume":"42","author":"Liu","year":"2023","journal-title":"Oncogene"},{"key":"R18-20251121","doi-asserted-by":"crossref","first-page":"7165","DOI":"10.2147\/OTT.S220027","article-title":"HOXC13-AS-miR-122-5p-SATB1-C-Myc feedback loop promotes migration, invasion and EMT process in glioma.","volume":"12","author":"Liu","year":"2019","journal-title":"Onco Targets Ther"},{"key":"R19-20251121","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/modpathol.2012.173","article-title":"Diagnostic implications of IDH1-R132H and OLIG2 expression patterns in rare and challenging glioblastoma variants.","volume":"26","author":"Joseph","year":"2013","journal-title":"Mod Pathol"},{"key":"R20-20251121","first-page":"651","article-title":"Glioblastoma with PNET-like components has a higher frequency of isocitrate dehydrogenase 1 (IDH1) mutation and likely a better prognosis than primary glioblastoma.","volume":"4","author":"Song","year":"2011","journal-title":"Int J Clin Exp Pathol"},{"key":"R21-20251121","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1017\/S1740925X04000249","article-title":"Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in mice.","volume":"1","author":"Lassman","year":"2004","journal-title":"Neuron Glia Biol"},{"key":"R22-20251121","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1200\/JCO.2011.37.5873","article-title":"Virchow 2011 or how to ID(H) human glioblastoma.","volume":"29","author":"DeAngelis","year":"2011","journal-title":"J Clin Oncol"},{"key":"R23-20251121","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.clinimag.2020.10.041","article-title":"Glioblastoma with a primitive neuroectodermal component: two cases with implications for glioblastoma cell-of-origin.","volume":"73","author":"Donabedian","year":"2021","journal-title":"Clin Imaging"},{"key":"R24-20251121","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.2005.02101.x","article-title":"Supratentorial primitive neuroectodermal tumours of the brain: multidirectional differentiation does not influence prognosis. A clinicopathological report of 18 patients.","volume":"46","author":"Vis\u00e9e","year":"2005","journal-title":"Histopathology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044072","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:01:59Z","timestamp":1763766119000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":24,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044072","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"2025-05-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}